Glucose-targeted therapy for subjects with type 2 diabetes mellitus: primum non nocere

Eur J Clin Invest. 2017 Oct;47(10):691-693. doi: 10.1111/eci.12791. Epub 2017 Aug 31.

Authors

Affiliations

¹ Diabetes Unit, Department of Internal Medicine, University of Genova and Ospedale Policlinico S. Martino, Genova, Italy.
² First Clinic of Internal Medicine, Department of Internal Medicine, University of Genova, Genova, Italy.
³ Ospedale Policlinico San Martino, Genova, Italy.
⁴ Centre of Excellence for Biomedical Research (CEBR), University of Genova, Genova, Italy.

PMID: 28746976
DOI: 10.1111/eci.12791

No abstract available

Publication types

Editorial

MeSH terms

Blood Glucose / analysis
Blood Glucose / drug effects*
Diabetes Mellitus, Type 2 / blood*
Diabetes Mellitus, Type 2 / diagnosis
Diabetes Mellitus, Type 2 / drug therapy*
Drug Delivery Systems
Female
Humans
Hyperglycemia / prevention & control*
Hypoglycemic Agents / administration & dosage*
Hypoglycemic Agents / pharmacology
Male
Severity of Illness Index
Treatment Outcome

Substances

Blood Glucose
Hypoglycemic Agents